                         SEQUENCE LISTING

<110>  University of Southern California
 
<120>  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR/ELASTIN-LIKE 
       POLYPEPTIDE FUSION PROTEINS AND USES THEREOF

<130>  00130-026WO1

<140>  Not yet assigned
<141>  2020-06-19

<150>  US 62/865,045
<151>  2019-06-21

<160>  30    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP consensus sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa at position 4 can be any amino acid

<400>  1

Val Pro Gly Xaa Gly 
1               5   


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP consensus sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa at position 5 can be any amino acid

<400>  2

Gly Val Pro Gly Xaa Gly 
1               5       


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  3

Val Pro Gly Ala Gly 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  4

Val Pro Gly Val Gly 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  5

Val Pro Gly Ile Gly 
1               5   


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  6

Val Pro Gly Leu Gly 
1               5   


<210>  7
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human GM-CSF consensus sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is selected from A or G

<220>
<221>  MISC_FEATURE
<222>  (79)..(79)
<223>  Xaa is selected from M or K

<220>
<221>  MISC_FEATURE
<222>  (100)..(100)
<223>  Xaa is selected from I or T

<220>
<221>  MISC_FEATURE
<222>  (106)..(106)
<223>  Xaa is selected from F or L

<400>  7

Ala Pro Xaa Arg Ser Pro Ser Pro Ser Thr Gln Pro Trp Glu His Val 
1               5                   10                  15      


Asn Ala Ile Gln Glu Ala Arg Arg Leu Leu Asn Leu Ser Arg Asp Thr 
            20                  25                  30          


Ala Ala Glu Met Asn Glu Thr Val Glu Val Ile Ser Glu Met Phe Asp 
        35                  40                  45              


Leu Gln Glu Pro Thr Cys Leu Gln Thr Arg Leu Glu Leu Tyr Lys Gln 
    50                  55                  60                  


Gly Leu Arg Gly Ser Leu Thr Lys Leu Lys Gly Pro Leu Thr Xaa Met 
65                  70                  75                  80  


Ala Ser His Tyr Lys Gln His Cys Pro Pro Thr Pro Glu Thr Ser Cys 
                85                  90                  95      


Ala Thr Gln Xaa Ile Thr Phe Glu Ser Xaa Lys Glu Asn Leu Lys Asp 
            100                 105                 110         


Phe Leu Leu Val 
        115     


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  8

Val Pro Gly Trp Gly 
1               5   


<210>  9
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  9

Val Pro Gly Tyr Gly 
1               5   


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  10

Val Pro Gly Phe Gly 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  11

Val Pro Gly Gly Gly 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  12

Val Pro Gly Ser Gly 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  ELP sequence

<400>  13

Val Pro Gly Thr Gly 
1               5   


<210>  14
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  14

Val Pro Gly Met Gly 
1               5   


<210>  15
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  ELP sequence

<400>  15

Val Pro Gly Asn Gly 
1               5   


<210>  16
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  16

Val Pro Gly Gln Gly 
1               5   


<210>  17
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  17

Val Pro Gly His Gly 
1               5   


<210>  18
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  18

Val Pro Gly Lys Gly 
1               5   


<210>  19
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  19

Val Pro Gly Arg Gly 
1               5   


<210>  20
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  20

Val Pro Gly Asp Gly 
1               5   


<210>  21
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  21

Val Pro Gly Glu Gly 
1               5   


<210>  22
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ELP sequence

<400>  22

Val Pro Gly Cys Gly 
1               5   


<210>  23
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  GM-CSF coding sequence


<220>
<221>  CDS
<222>  (1)..(381)

<400>  23
gct ccg gct cgt tct ccg tct ccg tct acc cag ccg tgg gaa cac gtt         48
Ala Pro Ala Arg Ser Pro Ser Pro Ser Thr Gln Pro Trp Glu His Val           
1               5                   10                  15                

aac gct atc cag gaa gct cgt cgt ctg ctg aac ctg tct cgt gac acc         96
Asn Ala Ile Gln Glu Ala Arg Arg Leu Leu Asn Leu Ser Arg Asp Thr           
            20                  25                  30                    

gct gct gaa atg aac gaa acc gtt gaa gtt atc tct gaa atg ttc gac        144
Ala Ala Glu Met Asn Glu Thr Val Glu Val Ile Ser Glu Met Phe Asp           
        35                  40                  45                        

ctg cag gaa ccg acc tgc ctg cag acc cgt ctg gaa ctg tac aaa cag        192
Leu Gln Glu Pro Thr Cys Leu Gln Thr Arg Leu Glu Leu Tyr Lys Gln           
    50                  55                  60                            

ggt ctg cgt ggt tct ctg acc aaa ctg aaa ggt ccg ctg acc atg atg        240
Gly Leu Arg Gly Ser Leu Thr Lys Leu Lys Gly Pro Leu Thr Met Met           
65                  70                  75                  80            

gct tct cac tac aaa cag cac tgc ccg ccg acc ccg gaa acc tct tgc        288
Ala Ser His Tyr Lys Gln His Cys Pro Pro Thr Pro Glu Thr Ser Cys           
                85                  90                  95                

gct acc cag atc atc acc ttc gaa tct ttc aaa gaa aac ctg aaa gac        336
Ala Thr Gln Ile Ile Thr Phe Glu Ser Phe Lys Glu Asn Leu Lys Asp           
            100                 105                 110                   

ttc ctg ctg gtt atc ccg ttc gac tgc tgg gaa ccg gtt cag gaa            381
Phe Leu Leu Val Ile Pro Phe Asp Cys Trp Glu Pro Val Gln Glu               
        115                 120                 125                       


<210>  24
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  24

Ala Pro Ala Arg Ser Pro Ser Pro Ser Thr Gln Pro Trp Glu His Val 
1               5                   10                  15      


Asn Ala Ile Gln Glu Ala Arg Arg Leu Leu Asn Leu Ser Arg Asp Thr 
            20                  25                  30          


Ala Ala Glu Met Asn Glu Thr Val Glu Val Ile Ser Glu Met Phe Asp 
        35                  40                  45              


Leu Gln Glu Pro Thr Cys Leu Gln Thr Arg Leu Glu Leu Tyr Lys Gln 
    50                  55                  60                  


Gly Leu Arg Gly Ser Leu Thr Lys Leu Lys Gly Pro Leu Thr Met Met 
65                  70                  75                  80  


Ala Ser His Tyr Lys Gln His Cys Pro Pro Thr Pro Glu Thr Ser Cys 
                85                  90                  95      


Ala Thr Gln Ile Ile Thr Phe Glu Ser Phe Lys Glu Asn Leu Lys Asp 
            100                 105                 110         


Phe Leu Leu Val Ile Pro Phe Asp Cys Trp Glu Pro Val Gln Glu 
        115                 120                 125         


<210>  25
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  25

Gly Gly Gly Gly Ser 
1               5   


<210>  26
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  26

Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Ser 
1               5                   10          


<210>  27
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  27

Gly Ser Thr Ser Gly Ser Gly Lys Ser Ser Glu Gly Lys Gly 
1               5                   10                  


<210>  28
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  28

Gly Ser Thr Ser Gly Ser Gly Lys Ser Ser Glu Gly Ser Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210>  29
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  29

Gly Ser Thr Ser Gly Ser Gly Lys Pro Gly Ser Gly Glu Gly Ser Thr 
1               5                   10                  15      


Lys Gly 
        


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide Linker

<400>  30

Glu Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Glu Phe 
1               5                   10                  


